title: Human immunodeficiency virus and liver disease forum 2010: conference proceedings.
abstract: Liver disease continues to represent a critical mediator of morbidity and mortality in those with human immunodeficiency virus (HIV) infection. The frequent presence and overlap of concomitant injurious processes, including hepatitis C virus and hepatitis B virus infections, hepatoxicity associated with antiretroviral therapeutic agents, alcohol, and other toxins, in the setting of immunosuppression lead to rapid fibrotic progression and early development of end-stage liver disease. This conference summary describes the proceedings of a state-of-the-art gathering of international experts designed to highlight the status of current research in epidemiology, natural history, pathogenesis, and treatment of HIV and liver disease.
authors: Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0595, USA. Kenneth.sherman@uc.edu
authors: Kenneth E
authors: KE
authors: Sherman
authors: David L
authors: DL
authors: Thomas
authors: Raymond T
authors: RT
authors: Chung
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D018450:Disease Progression; D058625:End Stage Liver Disease / Q000601:surgery; D006678:HIV; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy / Q000209:etiology*